Pharmacokinetics and Safety of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2 Open-Label Study
Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2019.08.019
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2020
Authors
Publisher
Elsevier BV